Home/Valar Labs/Paul Gerrard, MD

PG

Paul Gerrard, MD

VP Market Access & Regulatory Affairs

Therapeutic Areas

Valar Labs Pipeline

Drug	Indication	Phase
Vesta	Bladder Cancer (BCG therapy response)	Commercial
CHAI Biomarker	Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	Development/Validation

Leadership Team at Valar Labs

Co-founder & CEO

Viswesh Krishna

Co-founder & CTO

Trevor Royce, MD

Chief Medical Officer

Lesli Kiedrowski

VP Medical Affairs

VP Sales - Urology

View full Valar Labs profile